Research
Clinical Trials Currently Enrolling Patients at West Coast Gyn Oncology
GOG209- Phase III randomized study of Doxorubicin, Cisplatin, Paclitaxel, and Filgrastim (G-CSF) versus Carboplatin and Paclitaxel in patients with stage III or IV or recurrent endometrial cancer.
GOG212- Phase III randomized study of Paclitaxel versus Polyglutamate Paclitaxel as consolidation/maintenance therapy versus no further anticancer therapy until disease progression in patients with stage III or IV ovarian epithelial or primary peritoneal cancer.
GOG218- A phase III trial of Carboplatin and Paclitaxel plus Placebo versus Carboplatin and Paclitaxel plus concurrent Bevacizumab (nsc #704865, ind #7921) followed by Placebo, versus Carboplatin and Paclitaxel plus concurrent and extended Bevacizumab, in women with newly diagnosed, previously untreated, stage III (suboptimal) and all stage IV, epithelial ovarian or primary peritoneal cancer (awaiting IRB approval).